Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EPS Bio TechnologyROCO:4183 70 3-1 Month Momentum % is 4.29% as of Sep. 22, 2026. GuruFocus rates ROCO:4183 with a GF Score™ of 70/100 and a GF Value™ of NT$18.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 849 Medical Devices & Instruments companies, EPS Bio Technology ranks better than 59.72% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-22), EPS Bio Technology's 3-1 Month Momentum % is 4.29%.
The industry rank for EPS Bio Technology's 3-1 Month Momentum % or its related term are showing as below:
ROCO:4183's 3-1 Month Momentum % is ranked better than 59.72% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: 0.51
vs ROCO:4183: 4.29
EPS Bio Technology (ROCO:4183) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
EPS Bio Technology 3-1 Month Momentum % Related Terms
ROCO:4183 vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, EPS Bio Technology's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EPS Bio Technology 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EPS Bio Technology's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where EPS Bio Technology's 3-1 Month Momentum % falls into.
EPS Bio Technology (ROCO:4183) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS Bio Technology (ROCO:4183) has a 3-1 Month Momentum % of 4.29% as of Sep. 22, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on EPS Bio Technology and its competitors. According to the industry distribution chart, EPS Bio Technology ranks #342 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 40.3%.
Is EPS Bio Technology's 3-1 Month Momentum % too high?
EPS Bio Technology's current 3-1 Month Momentum % is 4.29%. The Medical Devices & Instruments industry median 3-1 Month Momentum % is 0.51. EPS Bio Technology's value of 4.29% is 741.2% above this industry median. Based on the distribution chart, EPS Bio Technology ranks #342 out of 849 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EPS Bio Technology has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EPS Bio Technology's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EPS Bio Technology ranks #342 out of 849 companies for 3-1 Month Momentum %. This puts EPS Bio Technology in the upper half of its industry. The industry median 3-1 Month Momentum % is 0.51. EPS Bio Technology's value of 4.29% is 741.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.51, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EPS Bio Technology's current 3-1 Month Momentum % of 4.29% is 741.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on EPS Bio Technology and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EPS Bio Technology's current 3-1 Month Momentum % is 4.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EPS Bio Technology stock overvalued right now?
Based on GuruFocus' analysis, EPS Bio Technology (ROCO:4183) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$18.38, compared to a current price of NT$13.65 — trading 25.7% below its estimated fair value. The current 3-1 Month Momentum % is 4.29% and 741.2% above the Medical Devices & Instruments industry median of 0.51. EPS Bio Technology's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For EPS Bio Technology (ROCO:4183), the current 3-1 Month Momentum % is 4.29% as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EPS Bio Technology (ROCO:4183) Overvalued in 2026?
Based on GuruFocus' analysis, EPS Bio Technology stock appears to be undervalued.
The current stock price of NT$13.65 is trading 25.7% below its estimated GF Value™ of NT$18.38.
GuruFocus considers EPS Bio Technology to be Modestly Undervalued.
Key valuation signals for ROCO:4183:
3-1 Month Momentum %: 4.29%
GF Value™: NT$18.38 vs. price of NT$13.65 (25.7% below fair value)
Industry Position: 741.2% above the Medical Devices & Instruments median (#342 of 849)
No single metric tells the full story. See the ROCO:4183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EPS Bio Technology Corp operates in medical equipment manufacturing, international trade, intellectual property, and research, design, development, manufacture and sale of blood glucose measuring system and cirrhosis testing system. Its products include Test sheet and Glucose machine. Geographically it operates in Germany, Iran, Kingdom of Saudi Arabia, Switzerland, Las Vegas, and Others with majority of the revenue deriving from Germany.
70GF Score
Get the complete analysis for ROCO:4183
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4183 has been successfully added to your 
